Literature DB >> 166750

Further observations on the response of the glomerular filtration rate to glucagon: comparison with secretin.

M Levy.   

Abstract

Glucagon causes marked elevations of glomerular filtration rate (GFR) in dogs when administered intravenously (i.v.) in small doses. The associated natriuresis is thought to be entirely due to increments in the filtered sodium load. In this study, renal denervation, thyroparathyroidectomy, and blockade of cholinergic, alpha- and beta-adrenergic, dopaminergic and histaminergic receptors did not prevent the usual glucagon-induced elevations of GFR or rate of sodium excretion (UNaV). This effect of glucagon was not mediated through the release of cyclic AMP, or by plasma compositional changes of Ca-2+, K+, or amino acids. Pure porcine secretin, in doses of 5--10 mug/min delivered either i.v. or into the left renal artery did not alter GFR; clearance of the p-aminohippurate (CPAH) or UNaV in either hydropenic or saline-loaded dogs. Nor did this polypeptide, structurally very similar to glucagon, abolish the effect of glucagon on GFR. It did, however, partially inhibit the glucagon-induced natriuresis, presumably by preventing a previously undetected glucagon action on tubular reabsorption of sodium.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166750     DOI: 10.1139/y75-010

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  3 in total

1.  Atrial natriuretic peptide receptors along the rat and rabbit nephrons: [125I] alpha-rat atrial natriuretic peptide binding in microdissected glomeruli and tubules.

Authors:  D Butlen; M Mistaoui; F Morel
Journal:  Pflugers Arch       Date:  1987-04       Impact factor: 3.657

2.  Studies on the mechanism of action of glucagon in strips of rabbit renal artery.

Authors:  G Gagnon; D Regoli; F Rioux
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

3.  Renal mechanism of action of rat atrial natriuretic factor.

Authors:  C L Huang; J Lewicki; L K Johnson; M G Cogan
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.